Medical Cannabis Rescheduled to Schedule III: A New Era for Research, Patients, and Policy
The landscape of cannabis policy in the United States underwent one of its most significant transformations in decades on April 23, 2026, when Acting Attorney General Todd Blanche issued a landmark order moving FDA-approved cannabis products and…